Buscar
27/01/2026
Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry
Vidal-Montal, P, Fabregat, A, Altabás-González, I, Pego-Reigosa, JM, Hernández-Martínez, A, Rua-Figueroa, I, Salman-Monte, T, Moriano, C, Segura, BT, Vela, P, Pareja-Martínez, A, García-Cirera, S, García-Villanueva, MJ, Garrote-Corral, S, Heredia, S, Riancho-Zarrabeitia, L, Manrique-Arija, S, Bernárdez, J, Magallares, B, Torrente-Segarra, V, Frade-Sosa, B, Gómez-Puerta, JA, Martinez-Barrio, J, Narvaez, J. Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry. Lupus Science & Medicine. 2026; 13(1)DOI:10.1136/lupus-2025-001825. PMID:41592907. IF:3.500(Q2/3D).
27/01/2026
Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis
Guinart-Cuadra, A, Brujats, A, Szafranska, J, Guerrero, R, Dinamarca, F, Cantó, E, Poca, M, Román, E, Sánchez-Ardid, E, Fajardo, J, Camps, M, Mulet, M, Soriano, G, Escorsell, A, Falcon-Perez, JM, Gonzalez, E, Ferrero-Gregori, A, Gely, C, Villalba, J, Bataller, R, Argemi, J, Osuna-Gómez, R, Vidal, S, Alvarado-Tapias, E. Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(3)DOI:10.3390/ijms27031258. PMID:41683683. IF:4.900(Q1/3D).
25/01/2026
In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis
Mallén, A, Rotllan, N, Griñán, R, Varela, C, Bertolino, E, Paloschi, V, Maegdefessel, L, Escolà-Gil, JC, Aran, JM, Sbraga, F, Blasco-Lucas, A, Torras, J, Navarro, E, Hueso, M. In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 2026; 330(1)DOI:10.1152/ajpcell.00242.2025. PMID:41289597. IF:4.700(Q1/1D).
25/01/2026
Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson's disease mild cognitive impairment: a randomized clinical trial
Puig-Davi, A, Moreu-Valls, A, Aracil-Bolaños, I, Fernandez-Cocaño, A, Rodríguez-Antigüedad, J, Kulisevsky, G, Horta-Barba, A, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson's disease mild cognitive impairment: a randomized clinical trial. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-31833-1. PMID:41582160. IF:3.900(Q1/2D).
22/01/2026
IL-6 in the spotlight: From cardiovascular pathophysiology to therapy
Preda, A, Tirandi, A, Leo, G, Di Vece, D, Vilahur, G, Bonaventura, A, Osto, E, Ministrini, S, Kraler, S, Kleinbogard, P, Camici, G, Carbone, F, Montecucco, F, Liberale, L. IL-6 in the spotlight: From cardiovascular pathophysiology to therapy. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70161. PMID:41340186. IF:3.600(Q1/2D).
22/01/2026
HDL function and composition in atherothrombotic cardiovascular disease with very high HDL-C
Padro, T, Muñoz-García, N, Fanlo-Maresma, M, Esteve-Luque, V, Cabré-Fernandez, P, Vilahur, G, Riera-Mestre, A, Badimon, L, Pinto, X. HDL function and composition in atherothrombotic cardiovascular disease with very high HDL-C. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70159. PMID:41413729. IF:3.600(Q1/2D).
20/01/2026
Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024
Formigo, GMS, Mazorra, Z, Olexen, C, Menéndez, T, Hadi, LA, Handgretinger, R, Hernandez, AAB, El Najjar, I, Coukos, G, Sabzevari, H, Bollard, C, Couriel, D, Wald, D, Hamieh, M, Briones, J, Al Kaabi, F, Ventura-Carmenate, Y. Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024. Frontiers in Immunology. 2026; 16DOI:10.3389/fimmu.2025.1650023. PMID:41641269. IF:5.900(Q1/2D).
20/01/2026
Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives
Gonzalez-Cucharero, C, Vilahur, G, Saura, M, Hinojar, R, Zamorano, JL, Zaragoza, C. Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70138. PMID:41131691. IF:3.600(Q1/2D).